Propionic acidemia

Analysis of mutant propionyl-CoA carboxylase enzymes expressed in Escherichia coli

Maja Chloupkova, Kenneth N. Maclean, Asem Alkhateeb, Jan P. Kraus

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Deficiency of propionyl-CoA carboxylase (PCC) results in propionic acidemia, an autosomal recessive disorder characterized by ketoacidosis sufficiently severe to cause neonatal death. PCC is involved in the catabolism of branched-chain amino acids, odd-chain fatty acids, and cholesterol. The enzyme is a biotin-dependent mitochondrial protein composed of two heterologous subunits arranged into an 800-kDa α6 β6 dodecameric structure. Approximately 60 mutations have been reported in the nuclear genes PCCA and PCCB that encode the two PCC subunits. The vast majority of these mutations have not been examined at the protein level. We present an initial characterization of 13 mutations located in exons 1, 3-7, and 12-14 of PCCB. After expression in E. coli, these recombinant mutant enzymes were analyzed for stability, biotinylation, α-β subunit interaction, and activity. Our results show a functional dichotomy in these PCCB mutations with some mutants (R44P, S106R, G131R, G198D, V205D, I408del, and M442T) capable of varying degrees of assembly but forming catalytically inactive PCC proteins. Other PCCB mutants (R165W, E168K, D178H, P228L, and R410W) that are PCC deficient in patient-derived fibroblasts, were found to be capable of expressing wild-type level PCC activity when assembled in our chaperone-assisted E. coli expression system. This result indicates that these mutations exert their pathogenic effect due to an inability to assemble correctly in patients' cells. This initial screen has identified a range of mutant PCC proteins that are sufficiently stable to be purified and subsequently used for structure-function analysis to further elucidate the complex relationship between genotype and phenotype in propionic acidemia.

Original languageEnglish
Pages (from-to)629-640
Number of pages12
JournalHuman Mutation
Volume19
Issue number6
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Methylmalonyl-CoA Decarboxylase
Propionic Acidemia
Escherichia coli
Enzymes
Mutation
Biotinylation
Branched Chain Amino Acids
Ketosis
Proteins
Mitochondrial Proteins
Biotin
Cause of Death
Exons
Fatty Acids
Fibroblasts
Cholesterol
Genotype
Phenotype

Keywords

  • Biotinylation
  • Glycinemia, ketotic
  • Mitochondria
  • Mutations
  • PA
  • PCC
  • PCCA
  • PCCB
  • Propionic acidemia
  • Propionicacidemia
  • Propionyl-CoA carboxylase
  • Screening

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Propionic acidemia : Analysis of mutant propionyl-CoA carboxylase enzymes expressed in Escherichia coli. / Chloupkova, Maja; Maclean, Kenneth N.; Alkhateeb, Asem; Kraus, Jan P.

In: Human Mutation, Vol. 19, No. 6, 2002, p. 629-640.

Research output: Contribution to journalArticle

Chloupkova, Maja ; Maclean, Kenneth N. ; Alkhateeb, Asem ; Kraus, Jan P. / Propionic acidemia : Analysis of mutant propionyl-CoA carboxylase enzymes expressed in Escherichia coli. In: Human Mutation. 2002 ; Vol. 19, No. 6. pp. 629-640.
@article{6c81d32618fc4a3d830360f909e45a4a,
title = "Propionic acidemia: Analysis of mutant propionyl-CoA carboxylase enzymes expressed in Escherichia coli",
abstract = "Deficiency of propionyl-CoA carboxylase (PCC) results in propionic acidemia, an autosomal recessive disorder characterized by ketoacidosis sufficiently severe to cause neonatal death. PCC is involved in the catabolism of branched-chain amino acids, odd-chain fatty acids, and cholesterol. The enzyme is a biotin-dependent mitochondrial protein composed of two heterologous subunits arranged into an 800-kDa α6 β6 dodecameric structure. Approximately 60 mutations have been reported in the nuclear genes PCCA and PCCB that encode the two PCC subunits. The vast majority of these mutations have not been examined at the protein level. We present an initial characterization of 13 mutations located in exons 1, 3-7, and 12-14 of PCCB. After expression in E. coli, these recombinant mutant enzymes were analyzed for stability, biotinylation, α-β subunit interaction, and activity. Our results show a functional dichotomy in these PCCB mutations with some mutants (R44P, S106R, G131R, G198D, V205D, I408del, and M442T) capable of varying degrees of assembly but forming catalytically inactive PCC proteins. Other PCCB mutants (R165W, E168K, D178H, P228L, and R410W) that are PCC deficient in patient-derived fibroblasts, were found to be capable of expressing wild-type level PCC activity when assembled in our chaperone-assisted E. coli expression system. This result indicates that these mutations exert their pathogenic effect due to an inability to assemble correctly in patients' cells. This initial screen has identified a range of mutant PCC proteins that are sufficiently stable to be purified and subsequently used for structure-function analysis to further elucidate the complex relationship between genotype and phenotype in propionic acidemia.",
keywords = "Biotinylation, Glycinemia, ketotic, Mitochondria, Mutations, PA, PCC, PCCA, PCCB, Propionic acidemia, Propionicacidemia, Propionyl-CoA carboxylase, Screening",
author = "Maja Chloupkova and Maclean, {Kenneth N.} and Asem Alkhateeb and Kraus, {Jan P.}",
year = "2002",
doi = "10.1002/humu.10085",
language = "English",
volume = "19",
pages = "629--640",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Propionic acidemia

T2 - Analysis of mutant propionyl-CoA carboxylase enzymes expressed in Escherichia coli

AU - Chloupkova, Maja

AU - Maclean, Kenneth N.

AU - Alkhateeb, Asem

AU - Kraus, Jan P.

PY - 2002

Y1 - 2002

N2 - Deficiency of propionyl-CoA carboxylase (PCC) results in propionic acidemia, an autosomal recessive disorder characterized by ketoacidosis sufficiently severe to cause neonatal death. PCC is involved in the catabolism of branched-chain amino acids, odd-chain fatty acids, and cholesterol. The enzyme is a biotin-dependent mitochondrial protein composed of two heterologous subunits arranged into an 800-kDa α6 β6 dodecameric structure. Approximately 60 mutations have been reported in the nuclear genes PCCA and PCCB that encode the two PCC subunits. The vast majority of these mutations have not been examined at the protein level. We present an initial characterization of 13 mutations located in exons 1, 3-7, and 12-14 of PCCB. After expression in E. coli, these recombinant mutant enzymes were analyzed for stability, biotinylation, α-β subunit interaction, and activity. Our results show a functional dichotomy in these PCCB mutations with some mutants (R44P, S106R, G131R, G198D, V205D, I408del, and M442T) capable of varying degrees of assembly but forming catalytically inactive PCC proteins. Other PCCB mutants (R165W, E168K, D178H, P228L, and R410W) that are PCC deficient in patient-derived fibroblasts, were found to be capable of expressing wild-type level PCC activity when assembled in our chaperone-assisted E. coli expression system. This result indicates that these mutations exert their pathogenic effect due to an inability to assemble correctly in patients' cells. This initial screen has identified a range of mutant PCC proteins that are sufficiently stable to be purified and subsequently used for structure-function analysis to further elucidate the complex relationship between genotype and phenotype in propionic acidemia.

AB - Deficiency of propionyl-CoA carboxylase (PCC) results in propionic acidemia, an autosomal recessive disorder characterized by ketoacidosis sufficiently severe to cause neonatal death. PCC is involved in the catabolism of branched-chain amino acids, odd-chain fatty acids, and cholesterol. The enzyme is a biotin-dependent mitochondrial protein composed of two heterologous subunits arranged into an 800-kDa α6 β6 dodecameric structure. Approximately 60 mutations have been reported in the nuclear genes PCCA and PCCB that encode the two PCC subunits. The vast majority of these mutations have not been examined at the protein level. We present an initial characterization of 13 mutations located in exons 1, 3-7, and 12-14 of PCCB. After expression in E. coli, these recombinant mutant enzymes were analyzed for stability, biotinylation, α-β subunit interaction, and activity. Our results show a functional dichotomy in these PCCB mutations with some mutants (R44P, S106R, G131R, G198D, V205D, I408del, and M442T) capable of varying degrees of assembly but forming catalytically inactive PCC proteins. Other PCCB mutants (R165W, E168K, D178H, P228L, and R410W) that are PCC deficient in patient-derived fibroblasts, were found to be capable of expressing wild-type level PCC activity when assembled in our chaperone-assisted E. coli expression system. This result indicates that these mutations exert their pathogenic effect due to an inability to assemble correctly in patients' cells. This initial screen has identified a range of mutant PCC proteins that are sufficiently stable to be purified and subsequently used for structure-function analysis to further elucidate the complex relationship between genotype and phenotype in propionic acidemia.

KW - Biotinylation

KW - Glycinemia, ketotic

KW - Mitochondria

KW - Mutations

KW - PA

KW - PCC

KW - PCCA

KW - PCCB

KW - Propionic acidemia

KW - Propionicacidemia

KW - Propionyl-CoA carboxylase

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=0036265176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036265176&partnerID=8YFLogxK

U2 - 10.1002/humu.10085

DO - 10.1002/humu.10085

M3 - Article

VL - 19

SP - 629

EP - 640

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 6

ER -